Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A15909 | 28655985 | Ann Gastroenterol | Circulating adipokines in children with nonalcoholic fatty liver disease: possible noninvasive diagnostic markers. | 2017 | Details |
| A15917 | 28652891 | World J Hepatol | Non-alcoholic fatty liver disease: An expanded review. | 2017 | Details |
| A15919 | 28652657 | World J Gastroenterol | Association of keratin 8/18 variants with non-alcoholic fatty liver disease and insulin resistance in Chinese patients: A case-control study. | 2017 | Details |
| A15920 | 28652650 | World J Gastroenterol | Role of non-steroidal anti-inflammatory drugs on intestinal permeability and nonalcoholic fatty liver disease. | 2017 | Details |
| A15923 | 28650518 | Liver Int | A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects. | 2017 | Details |
| A15925 | 28648927 | J Ethnopharmacol | Silibinin Capsules improves high fat diet-induced nonalcoholic fatty liver disease in hamsters through modifying hepatic de novo lipogenesis and fatty acid oxidation. | 2017 | Details |
| A15929 | 28647324 | Trends Endocrinol Metab | AMPK as a Therapeutic Target for Treating Metabolic Diseases. | 2017 | Details |
| A15930 | 28647291 | Clin Nutr | Genistein supplementation improves insulin resistance and inflammatory state in non-alcoholic fatty liver patients: A randomized, controlled trial. | 2017 | Details |
| A15933 | 28646531 | Br J Pharmacol | Morin, a novel liver X receptor α/β dual antagonist, has potent therapeutic efficacy for nonalcoholic fatty liver diseases. | 2017 | Details |
| A15940 | 28642059 | J Hepatol | New trends on obesity and NAFLD in Asia. | 2017 | Details |
| A15942 | 28641788 | Metabolism | Non-alcoholic fatty liver disease: A sign of systemic disease. | 2017 | Details |
| A15943 | 28641784 | Metabolism | Ultrasonographic fatty liver indicator detects mild steatosis and correlates with metabolic/histological parameters in various liver diseases. | 2017 | Details |
| A15949 | 28640216 | Nutrients | A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A15953 | 28638584 | Middle East J Dig Dis | The Prevalence of Non-alcoholic Fatty Liver Disease and Diabetes Mellitus in an Iranian Population. | 2017 | Details |
| A15954 | 28638220 | World J Gastroenterol | Green tea polyphenols ameliorate non-alcoholic fatty liver disease through upregulating AMPK activation in high fat fed Zucker fatty rats. | 2017 | Details |
| A15955 | 28637594 | Metabolism | Association of plasma dipeptidyl peptidase-4 activity with non-alcoholic fatty liver disease in nondiabetic Chinese population. | 2017 | Details |
| A15956 | 28637520 | Br J Nutr | Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. | 2017 | Details |
| A15959 | 28637104 | Korean J Gastroenterol | [Treatment Options in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15960 | 28637103 | Korean J Gastroenterol | [The Development of Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15961 | 28637102 | Korean J Gastroenterol | [The Progression of Liver Fibrosis in Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15962 | 28637101 | Korean J Gastroenterol | [Cardiovascular Risk in Patients with Non-alcoholic Fatty Liver Disease]. | 2017 | Details |
| A15968 | 28634585 | J Diabetes Res | High Plasma Glucagon Levels Correlate with Waist-to-Hip Ratio, Suprailiac Skinfold Thickness, and Deep Subcutaneous Abdominal and Intraperitoneal Adipose Tissue Depots in Nonobese Asian Indian Males with Type 2 Diabetes in North India. | 2017 | Details |
| A15975 | 28630692 | J Nutr Sci | Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop. | 2017 | Details |
| A15976 | 28630632 | Evid Based Complement Alternat Med | Erchen Decoction and Linguizhugan Decoction Ameliorate Hepatic Insulin Resistance by Inhibiting IRS-1Ser307 Phosphorylation In Vivo and In Vitro. | 2017 | Details |
| A15979 | 28628674 | PLoS One | Hepatic microvascular dysfunction and increased advanced glycation end products are components of non-alcoholic fatty liver disease. | 2017 | Details |
| A15980 | 28628263 | Hepatol Res | Insulin resistance increases the risk of incident type 2 diabetes mellitus in patients with non-alcoholic fatty liver disease. | 2017 | Details |
| A15985 | 28626963 | Exp Physiol | Exercise training modulates the hepatic renin-angiotensin system in fructose-fed rats. | 2017 | Details |
| A15996 | 28621339 | Nat Rev Endocrinol | Hepatokines: linking nonalcoholic fatty liver disease and insulin resistance. | 2017 | Details |
| A15999 | 28620012 | Clin Sci (Lond) | Metabolic disturbances of non-alcoholic fatty liver resemble the alterations typical for type 2 diabetes. | 2017 | Details |
| A16002 | 28618991 | Curr Med Chem | Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions. | 2018 | Details |
| A16010 | 28612550 | Sichuan Da Xue Xue Bao Yi Xue Ban | [Serum Wnt5a and Its Associations with Liver Steatosis and Fibrosis in Overweight and Obese People]. | 2017 | Details |
| A16012 | 28612285 | J Endocrinol Invest | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis. | 2017 | Details |
| A16015 | 28611297 | Oncotarget | Endogenous IL-33 has no effect on the progression of fibrosis during experimental steatohepatitis. | 2017 | Details |
| A16016 | 28611274 | Ann Hepatol | Meta-Analysis of Randomized Controlled Trials of Pharmacologic Agents in Non-alcoholic Steatohepatitis. | 2018 | Details |
| A16017 | 28609252 | Gut Microbes | Fecal microbiota transplantation in metabolic syndrome: History, present and future. | 2017 | Details |
| A16020 | 28607535 | Mediators Inflamm | Gender Disparity in the Relationship between Prevalence of Thyroid Nodules and Metabolic Syndrome Components: The SHDC-CDPC Community-Based Study. | 2017 | Details |
| A16021 | 28606575 | Nutrition | Good adherence to the Mediterranean diet reduces the risk for NASH and diabetes in pediatric patients with obesity: The results of an Italian Study. | 2017 | Details |
| A16032 | 28600116 | Surg Obes Relat Dis | Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy. | 2017 | Details |
| A16033 | 28599248 | Biomed Pharmacother | The multifaceted role of natriuretic peptides in metabolic syndrome. | 2017 | Details |
| A16034 | 28598982 | PLoS One | α-Mangostin ameliorates hepatic steatosis and insulin resistance by inhibition C-C chemokine receptor 2. | 2017 | Details |
| A16037 | 28598045 | J Assoc Physicians India | Soft Drinks Consumption and the Risk of Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A16040 | 28596784 | Front Genet | INDY-A New Link to Metabolic Regulation in Animals and Humans. | 2017 | Details |
| A16041 | 28596677 | World J Gastroenterol | Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease. | 2017 | Details |
| A16042 | 28596431 | Eur Respir J | Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease. | 2017 | Details |
| A16045 | 28595552 | Curr Med Chem | Pigment Epithelium-Derived Factor: A Novel Therapeutic Target for Cardiometabolic Diseases and Related Complications. | 2018 | Details |
| A16050 | 28593786 | Rev Esp Enferm Dig | Characterization of liver changes in ZSF1 rats, an animal model of metabolic syndrome. | 2017 | Details |
| A16051 | 28593739 | Hepatol Res | Systematic review and meta-analysis to determine the impact of iron depletion in dysmetabolic iron overload syndrome and non-alcoholic fatty liver disease. | 2017 | Details |
| A16054 | 28592311 | Trials | The effects of green cardamom on blood glucose indices, lipids, inflammatory factors, paraxonase-1, sirtuin-1, and irisin in patients with nonalcoholic fatty liver disease and obesity: study protocol for a randomized controlled trial. | 2017 | Details |
| A16056 | 28591572 | Cell Rep | Hepatic Diacylglycerol-Associated Protein Kinase Cε Translocation Links Hepatic Steatosis to Hepatic Insulin Resistance in Humans. | 2017 | Details |
| A16061 | 28587303 | Children (Basel) | The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16073 | 28585211 | Adv Exp Med Biol | Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16074 | 28585204 | Adv Exp Med Biol | Insulin Resistance, Obesity and Lipotoxicity. | 2017 | Details |
| A16076 | 28581362 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part II: PPAR-β/δ and PPAR-γ. | 2017 | Details |
| A16077 | 28581332 | Future Cardiol | PPARs: regulators of metabolism and as therapeutic targets in cardiovascular disease. Part I: PPAR-α. | 2017 | Details |
| A16079 | 28580850 | Orv Hetil | [Advances in the pathogenesis of non alcoholic fatty liver disease]. | 2017 | Details |
| A16080 | 28580278 | Mol Metab | FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis. | 2017 | Details |
| A16081 | 28579536 | Gastroenterology | Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity. | 2017 | Details |
| A16083 | 28578672 | Lipids Health Dis | Sake lees extract improves hepatic lipid accumulation in high fat diet-fed mice. | 2017 | Details |
| A16090 | 28577233 | Biol Trace Elem Res | Zinc and Selenium Co-supplementation Reduces Some Lipid Peroxidation and Angiogenesis Markers in a Rat Model of NAFLD-Fed High Fat Diet. | 2017 | Details |
| A16092 | 28575232 | J Clin Endocrinol Metab | Liver Safety of Statins in Prediabetes or T2DM and Nonalcoholic Steatohepatitis: Post Hoc Analysis of a Randomized Trial. | 2017 | Details |
| A16096 | 28573067 | World J Gastrointest Pathophysiol | Non-alcoholic fatty liver disease and cardiovascular risk. | 2017 | Details |
| A16103 | 28570615 | PLoS One | Liver biopsy in type 2 diabetes mellitus: Steatohepatitis represents the sole feature of liver damage. | 2017 | Details |
| A16106 | 28567448 | Sci Immunol | Type I Interferon Responses Drive Intrahepatic T cells to Promote Metabolic Syndrome. | 2017 | Details |
| A16107 | 28566439 | Eur J Endocrinol | MECHANISMS IN ENDOCRINOLOGY: The sexually dimorphic role of androgens in human metabolic disease. | 2017 | Details |
| A16108 | 28566408 | J Mol Endocrinol | 5-ALA ameliorates hepatic steatosis through AMPK signaling pathway. | 2017 | Details |
| A16111 | 28562560 | Medicine (Baltimore) | Triglyceride glucose-body mass index is effective in identifying nonalcoholic fatty liver disease in nonobese subjects. | 2017 | Details |
| A16116 | 28558676 | BMC Endocr Disord | Association of calf circumference with insulin resistance and non-alcohol fatty liver disease: the REACTION study. | 2017 | Details |
| A16118 | 28555633 | Am J Gastroenterol | Low Birthweight Increases the Likelihood of Severe Steatosis in Pediatric Non-Alcoholic Fatty Liver Disease. | 2017 | Details |
| A16120 | 28554682 | Clin Gastroenterol Hepatol | Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity. | 2017 | Details |
| A16121 | 28552096 | Dan Med J | The role of incretin hormones and glucagon in patients with liver disease. | 2017 | Details |
| A16122 | 28551355 | Trends Pharmacol Sci | Roles of Diacylglycerols and Ceramides in Hepatic Insulin Resistance. | 2017 | Details |
| A16124 | 28550439 | Obes Surg | Baseline Anthropometric and Metabolic Parameters Correlate with Weight Loss in Women 1-Year After Laparoscopic Roux-En-Y Gastric Bypass. | 2017 | Details |
| A16126 | 28550272 | J Biomed Res | Non-alcoholic fatty liver disease--a chronic disease of the 21<sup>st</sup> century. | 2018 | Details |
| A16127 | 28549912 | Exp Cell Res | Fatty liver and FGF21 physiology. | 2017 | Details |
| A16134 | 28545368 | Curr Med Chem | Improving Metabolic Control Through Functional Foods. | 2019 | Details |
| A16143 | 28540988 | Yonsei Med J | Pathologic Impact of Insulin Resistance and Sensitivity on the Severity of Liver Histopathology in Pediatric Non-Alcoholic Steatohepatitis. | 2017 | Details |
| A16144 | 28540984 | Yonsei Med J | Inverse Relationship between Hepatic Steatosis and Alanine Aminotransferase with Sex Hormone-Binding Globulin in Men. | 2017 | Details |
| A16145 | 28539915 | Front Microbiol | The Possible Role of Helicobacter pylori Infection in Non-alcoholic Fatty Liver Disease. | 2017 | Details |
| A16152 | 28536120 | FASEB J | Hepatocyte-specific sirtuin 6 deletion predisposes to nonalcoholic steatohepatitis by up-regulation of Bach1, an Nrf2 repressor. | 2017 | Details |
| A16154 | 28534852 | Nutrients | Effects of Ketogenic Diets on Cardiovascular Risk Factors: Evidence from Animal and Human Studies. | 2017 | Details |
| A16164 | 28529199 | J Clin Res Pediatr Endocrinol | Can Fetuin-A Be a Marker for Insulin Resistance and Poor Glycemic Control in Children with Type 1 Diabetes Mellitus? | 2017 | Details |
| A16166 | 28527877 | Pharmacol Rep | Esculetin ameliorates hepatic fibrosis in high fat diet induced non-alcoholic fatty liver disease by regulation of FoxO1 mediated pathway. | 2017 | Details |
| A16167 | 28527304 | Diabetes Res Clin Pract | Additive effect of non-alcoholic fatty liver disease on the development of diabetes in individuals with metabolic syndrome. | 2017 | Details |
| A16171 | 28525362 | Horm Mol Biol Clin Investig | FGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases. | 2017 | Details |
| A16177 | 28521680 | Curr Med Chem | Fatty Acids and Effects on In Vitro and In Vivo Models of Liver Steatosis. | 2019 | Details |
| A16180 | 28515456 | Sci Rep | Metabolomic analysis shows differential hepatic effects of T2 and T3 in rats after short-term feeding with high fat diet. | 2017 | Details |
| A16186 | 28511733 | Nutr Res Rev | Similarities and interactions between the ageing process and high chronic intake of added sugars. | 2017 | Details |
| A16191 | 28511161 | Wiad Lek | [The diagnostics and clinical pattern of nonalcoholic fatty liver disease in patients with pre-diabetes and type 2 diabetes and obesity]. | 2017 | Details |
| A16197 | 28508477 | Hepatology | The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance. | 2017 | Details |
| A16198 | 28508194 | Endocrine | Fatty liver as a risk factor for progression from metabolically healthy to metabolically abnormal in non-overweight individuals. | 2017 | Details |
| A16202 | 28507837 | Cureus | Non-Alcoholic Fatty Liver Disease Association with Cardiac Arrhythmias. | 2017 | Details |
| A16204 | 28507343 | Sci Rep | Non-alcoholic fatty liver disease, vascular inflammation and insulin resistance are exacerbated by TRAIL deletion in mice. | 2017 | Details |
| A16216 | 28503750 | Diabetes Obes Metab | Comparative effects of liraglutide 3 mg vs structured lifestyle modification on body weight, liver fat and liver function in obese patients with non-alcoholic fatty liver disease: A pilot randomized trial. | 2017 | Details |
| A16228 | 28498022 | Curr Med Res Opin | Thyroid hormone analogs for the treatment of dyslipidemia: past, present, and future. | 2017 | Details |
| A16234 | 28494529 | Clin Mol Hepatol | NASH Therapy: omega 3 supplementation, vitamin E, insulin sensitizers and statin drugs. | 2017 | Details |
| A16237 | 28492501 | Nutrients | Urinary Metabolomics in Pediatric Obesity and NAFLD Identifies Metabolic Pathways/Metabolites Related to Dietary Habits and Gut-Liver Axis Perturbations. | 2017 | Details |
| A16238 | 28490707 | Zhong Nan Da Xue Xue Bao Yi Xue Ban | [Effect of NF-κB on the pathogenic course of non-alcoholic fatty liver disease]. | 2017 | Details |
| A16239 | 28490610 | Diabetes | Mechanisms of Insulin Resistance in Primary and Secondary Nonalcoholic Fatty Liver. | 2017 | Details |
| A16241 | 28489136 | Rev Assoc Med Bras (1992) | Hyperferritinemia in patients with nonalcoholic fatty liver disease. | 2017 | Details |
| A16244 | 28487551 | Int J Obes (Lond) | High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance. | 2017 | Details |